2019 BioPacific Conference (21th Annual Conference of CABS) Agenda

Theme: Pursuing Science for Cure

San Mateo Marriott, 1770 South Amphlett Blvd, San Mateo, CA 94402

8:00 AM – 8:40 AM REGISTRATION
8:40 AM – 8:45 AM Welcome Remarks
Yang Tian, PhD, President-elect of CABS and 2019 BioPacific Conference Organizing Committee Chair
8:45 AM – 9:00 AM State of the Society
Yan Wang, PhD, President of CABS
9:00 AM – 9:30 AM Keynote: Biomarkers and Translational Research in Cancer Therapy
Ron Mazumder, PhD, Vice President and Global Head of Oncology Biomarker Development and Companion Diagnostics, Genentech
9:30 AM – 10:00 AM Talk title: New Diagnostics Ecosystem to Accelerate Drug Discovery and Medical Innovation
Jason Liu, PhD, MBA, CEO, WuXi Diagnostics
10:00 AM-10:50 AM CABS K. Fong Award in Life Sciences
Presenter: Kenneth Fong, PhD, Chairman, Kenson Ventures
Awardee: John Oyler, Founder, CEO and Chairman of BeiGene
10:50 AM-11:00 AM – Coffee Break
11:00 AM – 11:30 AM Designing Therapies to Cure HIV
Romas Geleziunas, PhD, Executive Director, Gilead Sciences
11:30 AM – 11:40 AM Fireside Chat:
Moderator: Alex J. Zhang, PhD, CEO, Hanhai Silicon Valley Jun Xiang, PhD, General Manager, ChemPartner Biologics
11:40 AM – 12:05 PM Panel Discussion:Key Developments: CFIUS, Export Control Reform, and Recent Decisions Affecting Life Sciences Investment and Licensing
Joseph Benkert, Senior Advisor, Morrison Foerster
12:05 AM – 12:30 PM Panel Discussion: IP, legal and investment in Life Sciences
Moderator, Huijun Zhou, FACMG, Founder and CEO, iDNA
Panelists, Joseph Benkert, Senior Advisor, Morrison Foerster
Panelists,Greg Scott, Founder and Chairman, ChinaBio
Panelists,Michael Su, MS, JD, Attorney, Intellectual Property Law, Finnegan
Panelists,Vivien Wang, MS, Partner, Deloitte
12:30 PM – 1:30 PM – Lunch Break
12:45 PM – 1:15 PM Lunch Workshop: Humanized Mouse Model Accelerates Biomedicine Research & Drug Development
Ming Yin, PhD, VP, Beijing VitalStar Biotechnology
1:30 PM – 2:00 PM New Approaches To Neurodegenerative Disease Drug Discovery and Development
Zach Sweeney, PhD, Head of Therapeutic Discovery, Denali Therapeutics
2:00 PM – 2:30 PM Panel Discussion: Innovative and Collaborative Contract Services to Accelerate Drug Development
Moderator: Jiangwen Majeti, PhD, MBA, Genentech
Panelists: Tao He, PhD, Co-Founder and SVP, Joinn Biologics
Connie Sun, PhD, SVP, Pharmaron Mike Chen, CEO, AcroBio
2:30 PM – 3:00 PM Applying Precision Medicine One Patient at a Time
Shivaani Kummar, MD, Professor of Medicine and Director of Phase I Clinical Research Program (Oncology), Stanford University
3:00 PM – 3:10PM – Coffee Break
3:10 PM – 3:50 PM Panel Discussion: innovative therapy in oncology, what is next?
Moderator: Cheni Kwok, PhD, CLP, Managing Partner and Founder, Linear Dreams
Panelists, Scott Liu, PhD, CEO, Henlius
Panelists, Jean Cui, PhD, CSO, Turning Point Therapeutics
Panelists, Mark Nevins, MS, VP of Business Development, Apexigen
Panelists, Peiwen Yu, PhD, VP of Discovery Biology, Exelixis
Panelists, Tara Arvedson, PhD, Director of Research, Amgen
Panelists, Charlene Liao, PhD, Co-founder, President and CEO, Immune-Onc Therapeutics
Panelists, Yanyan Zheng, PhD, Principle Scientist, Merck
3:50 PM – 4:20 PM Talazoparib: From Virtual Drug Discovery to FDA Approval
Leonard Post, PhD, CSO, Vivace Therapeutics
4:20 PM – Conference Adjourned
5:00 PM – 7:00 PM – Post-conference Reception Sponsored by Diamond Sponsors (Engage room and courtyard)
8:40 AM – 4:45 PM – Conference (Convene room)
8:40 AM – 7:00 PM – Partnering (Synergy 1 room)
8:00 AM – 7:00 PM – Exhibition hall (Inspire room)